Adjuvant arthritis as a model of inflammatory cachexia
- PMID: 9082942
- DOI: 10.1002/art.1780400320
Adjuvant arthritis as a model of inflammatory cachexia
Abstract
Objective: To determine whether adjuvant arthritis (AA) leads to changes in body composition and cytokine production similar to those seen in patients with rheumatoid arthritis.
Methods: AA was induced in Lewis rats using Freund's complete adjuvant. Body cell mass was measured by determining the concentration of total exchangeable potassium using 42K gavage. Splenocyte production of interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF alpha) was measured by bioassay. Weight and food intake were also measured.
Results: Animals that developed AA lost 6% of their body weight by the onset of clinically evident arthritis (day 14; P < 0.01) and lost 20% by the end of the inflammatory phase of AA (day 28; P < 0.0001). Body cell mass fell 24.7 +/- 8.6% (mean +/- SEM) in animals with AA, but did not change significantly in controls (increase of 6.3 +/- 7.9%) (P < 0.03). Pair-fed animals lost one-fourth of the weight lost by the animals with AA (P < 0.01), indicating that anorexia alone does not explain inflammatory cachexia. Weight loss was correlated with TNF alpha production by spleen mononuclear cells (r = 0.68, P < 0.007), and a weaker correlation was seen with IL-1 production (r = 0.45, P < 0.04).
Conclusion: AA in rats is a useful model of inflammatory cachexia that mimics the human pathophysiology in important ways, and is consistent with cytokine-driven cachexia in chronic inflammatory arthritis.
Similar articles
-
Effects of aging and cytokine blockade on inflammatory cachexia.Clin Exp Rheumatol. 2004 Jan-Feb;22(1):85-90. Clin Exp Rheumatol. 2004. PMID: 15005009
-
Enhanced activity of hormone sensitive lipase (HSL) in mesenteric but not epididymal fat correlates with higher production of epinephrine in mesenteric adipocytes in rat model of cachectic rheumatoid arthritis.Autoimmunity. 2016 Jun;49(4):268-76. doi: 10.3109/08916934.2016.1164145. Epub 2016 Apr 12. Autoimmunity. 2016. PMID: 27068752
-
Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats.Int Immunopharmacol. 2004 Dec 15;4(13):1625-32. doi: 10.1016/j.intimp.2004.07.022. Int Immunopharmacol. 2004. PMID: 15454115
-
Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Front Nutr. 2014 Nov 24;1:20. doi: 10.3389/fnut.2014.00020. eCollection 2014. Front Nutr. 2014. PMID: 25988122 Free PMC article. Review.
-
Catabolic proinflammatory cytokines.Curr Opin Clin Nutr Metab Care. 1998 May;1(3):245-51. doi: 10.1097/00075197-199805000-00002. Curr Opin Clin Nutr Metab Care. 1998. PMID: 10565356 Review.
Cited by
-
The urea cycle in the liver of arthritic rats.Mol Cell Biochem. 2003 Jan;243(1-2):97-106. doi: 10.1023/a:1021695625457. Mol Cell Biochem. 2003. PMID: 12619894
-
Construction of a two-dimensional artificial antioxidase for nanocatalytic rheumatoid arthritis treatment.Nat Commun. 2022 Apr 13;13(1):1988. doi: 10.1038/s41467-022-29735-1. Nat Commun. 2022. PMID: 35418125 Free PMC article.
-
A study of the anti-inflammatory effect of the leaves of Psidium guajava Linn. on experimental animal models.Pharmacognosy Res. 2010 Sep;2(5):313-7. doi: 10.4103/0974-8490.72331. Pharmacognosy Res. 2010. PMID: 21589759 Free PMC article.
-
Ameliorative Effects of a Polyphenolic Fraction of Cinnamomum zeylanicum L. Bark in Animal Models of Inflammation and Arthritis.Sci Pharm. 2013 Apr-Jun;81(2):567-89. doi: 10.3797/scipharm.1301-16. Epub 2013 Feb 25. Sci Pharm. 2013. PMID: 23833722 Free PMC article.
-
Amelioration of the rheumatoid arthritis microenvironment using celastrol-loaded silver-modified ceria nanoparticles for enhanced treatment.J Nanobiotechnology. 2025 May 22;23(1):372. doi: 10.1186/s12951-025-03388-w. J Nanobiotechnology. 2025. PMID: 40405278 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources